50
Participants
Start Date
September 23, 2015
Primary Completion Date
May 14, 2021
Study Completion Date
May 14, 2021
Proflavine
0.01% Proflavine applied topically to the cervix after colposcopy and HRME cervical images obtained.
HRME Imaging
HRME images obtained from one visually normal cervical site, and from up to 3 visually abnormal lesions based on exam and/or colposcopic findings.
Phone Call
Study staff follow up with participant by phone one month after procedure.
Colposcopy
Colposcopy performed after visual inspection of cervix.
Acetic Acid
3 - 5% added to cervix before visual inspection.
Lyndon B. Johnson General Hospital, Houston
University of Texas MD Anderson Cancer Center, Houston
National Cancer Institute (NCI)
NIH
National Institutes of Health (NIH)
NIH
M.D. Anderson Cancer Center
OTHER